NL-OMON37273已完成不适用
A study to investigate the analgesic effects of buprenorphine and milnacipram in healthy volunteers. - Interaction pain study between buprenorphine and milnacipran.
Dr. Reddy's Laboratories Ltd.0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Signed informed consent prior to any study-mandated procedure.
- •2. Caucasian (white) males aged between 18 and 45 years (inclusive) at screening.
- •3. Body mass index (BMI) between 18 and 30 kg/m2 (exclusive) at screening.
- •4. No clinically significant findings on the physical examination at screening.
- •5. Ability to communicate well with the investigator in the local language and to understand and comply with the requirements of the study.
- •6. Systolic blood pressure (SBP) between 100 and 140 mmHg (inclusive).
- •7. Diastolic blood pressure (DBP) between 45 and 90 mmHg (inclusive).
- •8. Heart rate (HR) between 45 and 100 b.p.m. (inclusive).
- •9. Haematology and clinical chemistry results within normal range (to a clinically relevant extent at screening).
- •10. Negative results for urine drug tests at screening.
- •11. 12-lead electrocardiogram (ECG) normal or to have no clinically significant alterations.
排除标准
- •1. Known hypersensitivity to buprenorphine and/or milnacipran.
- •2. Previous treatment with any prescribed or OTC medications (including herbal medicines such as St John*s Wort), within 7 days prior to screening.
- •3. Treatment with another investigational drug within 3 months prior to screening.
- •4. History or clinical evidence of alcoholism or drug abuse.
- •5. Treatment with or consumption of inducers or inhibitors of CYP3A4 (e.g. grapefruit (juice), star fruit) or CYP2C8 within 7 days prior to screening.
- •6. Smoking within 3 months prior to screening and inability to refrain from smoking during the course of study. Excessive caffeine consumption, defined as >= 800 mg per day at screening.
- •7. History or clinical evidence of any disease, and/or existence of any surgical or medical condition, which might interfere with the absorption, distribution, metabolism or excretion of the study drugs.
- •8. Loss of 250 mL or more of blood within 3 months prior to screening.
- •9. Positive results from the hepatitis serology at screening.
- •10. Positive results from the HIV serology at screening.
- •11. Any circumstances or conditions, which, in the opinion of the investigator, may affect full participation in the study or compliance with the protocol.
- •12. Legal incapacity or limited legal capacity at screening.;All clinical judgments will be done by the study physician and he or she will decide eligibility of the subjects based on individual evaluation for each case. Any vital signs or laboratory values which are out of the normal range for the age group should be excluded unless the study physician and/or the principal investigator deems not to be clinically significant.
研究者
相似试验
进行中（未招募）
不适用
A study of the effect of buprenorphine in combination with milnacipran in a pain model in healthy volunteers.Pain therapeutics, neuropathic pain, nociceptive pain, synergism between opioids and TCA.MedDRA version: 14.1Level: LLTClassification code 10054095Term: Neuropathic painSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 14.1Level: LLTClassification code 10066714Term: Acute painSystem Organ Class: 10018065 - General disorders and administration site conditionsEUCTR2012-002302-43-NLDr. Reddy's Laboratories Ltd.
已完成
4 期
A pilot study examining the analgesic effect of ascending buprenorphine doses in opioid dependent peoplePainOpioid dependenceAnaesthesiology - Pain managementMental Health - AddictionACTRN12614001038684South Eastern Sydney Local Health District8
尚未招募
不适用
ovel Herbal Enema of Versus Reference Standard Dashamula Taila Enema in the pain managementCTRI/2022/12/048239il
招募中
不适用
A study on the effectiveness of analgesics in patients undergoing thyroidectomyKCT0008131The Catholic University of Korea, Seoul St. Mary's Hospital62
尚未招募
不适用
Comparative study to evaluate the pain relieving effect of two drug mixtures -bupivacaine with buprenorphine and bupivacaine with dexmedetomidine in ultrasound guided chest wall muscle plane block in patients undergoing breast cancer surgeriesCTRI/2022/09/046092ESIC Medical College and PGIMSR